OBARA Naoshi
- Articles
- Profiling of Multiple Gene Mutations In Myelodysplastic Syndromes Using High-Throughput Resequenceing Combined with Barcode Labeling
Nagata Yasunobu; Sanada Masashi; Yoshida Kenichi; Nakaya ...
BLOOD/116(21)/pp.1635-1635, 2010-11 - Caffeine と taurine の併用による持久力および乳酸に及ぼす効果
今川 貴彦; 松本 健; 小原 直; 鈴木 教郎; 山本 雅之; 今川 重彦
The journal of clinical sports medicine/23(2)/pp.207-210, 2006-02 - Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange
越野 繭子; 工藤 大輔; 大越 靖; 小原 直; 清水 誠一; 向井 陽美; 鈴川 和己; 長谷川 雄一; 小島...
The Japanese journal of clinical hematology/51(2)/pp.127-131, 2010-02 - Myelodysplastic syndrome accompanied by basophilia and eosinophilia with t(5;12)(q31;p13)
Katsura Yukitaka; Suzukawa Kazumi; Nanmoku Toru; Nemoto ...
CANCER GENETICS AND CYTOGENETICS/178(1)/pp.85-88, 2007-10 - Detection of the STAT5B-RARA fusion transcript in acute promyelocytic leukemia with the normal chromosome 17 on G-banding
Kusakabe Manabu; Suzukawa Kazumi; Nanmoku Toru; Obara Na...
EUROPEAN JOURNAL OF HAEMATOLOGY/80(5)/pp.444-447, 2008-05 - Anti Tumor Effect of 2-Oxoglutarate through Inhibition of Angiogenesis in a Murine Tumor Model
Matsumoto Ken; Obara Naoshi; Horie Masaki; Naka Ayano; Ut...
BLOOD/112(11)/pp.567-567, 2008-11 - Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model
Matsumoto Ken; Obara Naoshi; Ema Masatsugu; Horie Masaki...
CANCER SCIENCE/100(9)/pp.1639-1647, 2009-09 - Rescue of Erythropoietin-Deficient Mice From Anemia by Complementation with BAC Transgene.
Yamazaki Shun; Suzuki Norio; Obara Naoshi; Pan Xiaoqing; ...
BLOOD/114(22)/pp.1397-1397, 2009-11 - Hematological aspects of a novel 9-aminoanthracycline, amrubicin
Obara N; Imagawa S; Nakano Y; Yamamoto M; Noguchi T; Naga...
CANCER SCIENCE/94(12)/pp.1104-1106, 2003-12 - Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome
Imagawa S; Yamaguchi Y; Ogawa K; Obara N; Suzuki N; Yamamoto M...
RESPIRATION/71(1)/pp.24-29, 2004-01 - A novel GATA-specific inhibitor (GSI) rescues anemia of chronic disease by oral administration.
Imagawa S; Nakano Y; Obara N; Suzuki N; Nagasawa T; Yamam...
BLOOD/102(11:Part 1)/pp.1859-0, 2003-11 - Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease
Nakano Y; Imagawa S; Matsumoto K; Stockmann C; Obara N; Suzuki...
BLOOD/104(13)/pp.4300-4307, 2004-12 - 2-oxoglutarate down-regulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxia inducible factor-1 alpha and inhibits angiogenesis.
Imagawa S; Matsumoto K; Obara N; Suzuki N; Nagasawa T; Ya...
BLOOD/106(11:Part 2)/pp.3957-0, 2005-11 - 2-Oxoglutarate downregulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxia-inducible factor-1 alpha and inhibits angiogenesis
Matsumoto Ken; Imagawa Shigehiko; Obara Naoshi; Suzuki N...
JOURNAL OF CELLULAR PHYSIOLOGY/209(2)/pp.333-340, 2006-11
- Profiling of Multiple Gene Mutations In Myelodysplastic Syndromes Using High-Throughput Resequenceing Combined with Barcode Labeling